BioCentury
ARTICLE | Company News

Boehringer Ingelheim receives FDA approval

April 14, 2000 7:00 AM UTC

Boehringer Ingelheim received FDA marketing approval for its Mobic meloxicam tablets to treat osteoarthritis. Mobic, a non-steroidal anti-inflammatory drug (NSAID), will be marketed in the U.S. by Boe...